NEW AIDH DIGITAL STRATEGY ADDS PILLAR TO PREVIOUS AIMS Nurturing, supporting and advancing AIDH members’ professional lives
With
Anja Nikolic,
Chief Executive Officer
Australasian Institute of Digital Health
SEGMENT
Filmed in Melbourne & Sydney | March 2026
Australasian Institute of Digital Health (AIDH), today has released the AIDH Strategic Plan for 2026–2028, recently approved by the Board. This plan acts as a roadmap, as well as a shared statement of purpose and intent, guiding where AIDH will focus its effort, investment and voice over the next three years.
Australian Health Journal spoke with Anja Nikolic, AIDH Chief Executive Officer on AIDH’s role as a hub for collaboration, knowledge advancement and thought leadership across the sector.
Drawing upon the previous strategic plan ending 2025, the new plan as a new pillar.
The plan commits AIDH to continuing its work in building a highly skilled and capable workforce, shaping healthcare through strong thought leadership, and fostering a diverse and engaged community. Importantly, it introduces an additional strategic aim — nurturing a thriving and growing membership — because its impact relies on a strong, supported and connected member base.
Underlying themes are AIDH’s commitment to organisational excellence, guided by its values of professionalism, excellence, integrity, respect and teamwork.
The Strategic Plan was developed collaboratively, drawing on the insight and experience of staff, the Board, members and stakeholders.
AIDH members and stakeholders are invited to read the plan and consider how they can support its delivery — through their involvement, their ideas, and their advocacy for AIDH and the digital health community.
Source: Supplied and adapted
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Substantial increase in allied health funding for veterans through DVA
The Australian Federal 2026–27 Budget included several significant announcements relating to allied health services for veterans, largely tied to the Government’s response to recommendations from the Royal Commission into Defence and Veteran Suicide.
-
Success in WA pilot to observe babies showing delays in social interaction & communication development
Inklings – led by The Kids Research Institute Australia – is a program for babies aged 6-18 months whose communications skills are developing differently to expected milestones. In early 2025 it has completed the first year of a pilot program.
At the time of filming (Nov 2024), Inklings has received more then 300 enquiries across WA and started to deliver services to 160 children, with almost 60 who have completed the program.
